Preview

Артериальная гипертензия

Расширенный поиск

ВЗАИМОДЕЙСТВИЕ МЕЖДУ СИМПАТИЧЕСКОЙ НЕРВНОЙ СИСТЕМОЙ И РЕНИН-АНГИОТЕНЗИНОВОЙ СИСТЕМОЙ. РОЛЬ В ПОВЫШЕНИИ АРТЕРИАЛЬНОГО ДАВЛЕНИЯ

https://doi.org/10.18705/1607-419X-2012-18-6-577-583

Полный текст:

Об авторе

А. О. Конради
ФГБУ «Федеральный Центр сердца, крови и эндокринологии им. В.А. Алмазова» Министерства здравоохранения РФ
Россия


Список литературы

1. Richardson D., Stella A., Leonetti G. et al. Mechanisms of renal release of renin by electrical stimulation of the brain system in the cat // Circ. Res. – 1974. – Vol. 34, № 4. – P. 425-434.

2. Grassi G., Seravalle G., Turri C., Mancia G. Sympathetic nerve traffic responses to surgical removal of pheochromocytoma // Hypertension. – 1999. - Vol. 34, № 3. - P. 461–465.

3. Shepherd J.T., Mancia G. Reflex control of the human cardiovascular system // Rev. Physiol. Biochem. Pharmacol. – 1986. - Vol. 105. - P. 1-99.

4. Grassi G., Cattaneo B.M., Seravalle G., Lanfranchi A., Mancia G. Baroreflex control of sympathetic nerve activity in essential and secondary hypertension // Hypertension. 1998; Vol. 31, № 1. - P. 68–72.

5. Branderbergen G., Chafiri C., Muzet A., Saini J., Simon C., Follenius M. Renin as a biological marker of the NREM-REM sleep cycle: effect of REM sleep suppression // J. Sleep Res. – 1994. - Vol. 3, № 1. - P. 30-35.

6. Philips M.I. Functions of angiotensin in the central nervous system // Ann. Rev. Physiol. – 1987. - Vol. 49. - P. 413-435.

7. Cody R.J. The sympathetic nervous system and the renin-angiotensin-aldosterone system in cardiovascular disease // Am. J. Cardiol. – 1997. - Vol. 80, № 9В. - P. 9J-14J.

8. Di Bona G.F. Peripheral and central interactions between the renin-angiotensin system and the renal sympathetic nerves in control of renal function // Ann. N. Y. Acad. Sci. – 2001. – Vol. 940. - P. 395-406.

9. Reid I.A. Interaction between angiotensin II, sympathetic nervous system and baroreceptor reflexes in regulation of blood pressure // Am. J. Physiol. – 1992. - Vol. 262. - P. E763-E778.

10. Grassi G. Sympathetic deactivation as a goal of nonpharmacologic and pharmacologic antihypertensive treatment: rationale and options // Curr. Hypertens. Rep. – 2003. - Vol. 5, № 4. - P. 277-280.

11. Klein I.H., Ligtenberg G., Oey P.L., Koomans H.A., Blankestijn P.J. Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure // J. Am. Soc. Nephrol. – 2003. - Vol. 14, № 2. - P. 425-430.

12. Luft F.C., Wilcox C.S., Unger T. et al. Angiotensin-induced hypertension in the rat. Sympathetic nerve activity and prostaglandins // Hypertension. – 1989. - Vol. 14, № 4. - P. 396–403.

13. Abboud F.M. Effects of sodium, angiotensin and steroids on vascular reactivity in man // Fed. Proc. – 1974. - Vol. 33, № 2. - P. 143-149.

14. Morganti A., Grassi G., Giannattasio C. et al. Effect of angiotensin-converting enzyme inhibition on cardiovascular regulation during sympathetic activation in sodium-replete patients with essential hypertension // J. Hypertens. – 1989. - Vol. 7, № 10. - P. 825-835.

15. Giannattasio C., Cattaneo B.M., Omboni S. et al. Sympathomoderating influence of benazepril in essential hypertension // J. Hypertens. – 1992. - Vol. 10, № 4. - P. 373-778.

16. Li Q., Dale W.E., Hasser E.M., Blaine E.H. Acute and chronic angiotensin hypertension: neural and nonneural components, time course, and dose dependency // Am. J. Physiol. – 1996. – Vol. 271, № 1, Pt. 2. – P. R200–R207.

17. Fink G.D. Long-term sympatho-excitatory effect of angiotensin II: a mechanism of spontaneous and renovascular hypertension // Clin. Exp. Pharmacol. Physiol. – 1997. – Vol. 24, № 1. – P. 91–95.

18. Fuller P.J., Young M.J. Mechanisms of mineralocorticoid action // Hypertension. – 2005. – Vol. 46, № 6. – P. 1227–1235.

19. Takahashi H., Yoshika M., Komiyama Y., Nishimura M. The central mechanism underlying hypertension: a review of the roles of sodium ions, epithelial sodium channels, the renin–angiotensin–aldosterone system, oxidative stress and endogenous digitalis in the brain // Hypertens. Res. – 2011. – Vol. 34, № 11. – P. 1147–1160.

20. Malpas S. Sympathetic nervous system overactivity and its role in the development of cardiovascular disease // Physiol. Rev. – 2010. – Vol. 90, № 2. – P. 513–557.

21. Lindpainter K., Ganten D. The cardiac renin-angiotensin system: an appraisal of present experimental and clinical evidence // Circ. Res. – 1991. - Vol. 68, № 4. - P. 905-921.

22. Perondi R., Saino A., Tio R.A. et al. ACE inhibition attenuates sympathetic coronary vasoconstriction in patients with coronary artery disease // Circulation. – 1992. - Vol. 85, № 6. - P. 2004-2013.

23. Saino A., Pomidossi G., Perondi R. et al. Intracoronary angiotensin II potentates coronary sympathetic vasoconstrictor in humans // Circulation. – 1997. - Vol. 96, № 1. – Р. 148-153.

24. Mancia G., Dell’Oro R., Quarti-Trevano R. et al. Angiotesin-sympathetic system intercations in cardiovascular and metabolic disease // J. Hypertens. – 2005. - Vol. 24, suppl. 1. -P. S51-S56.


Для цитирования:


Конради А.О. ВЗАИМОДЕЙСТВИЕ МЕЖДУ СИМПАТИЧЕСКОЙ НЕРВНОЙ СИСТЕМОЙ И РЕНИН-АНГИОТЕНЗИНОВОЙ СИСТЕМОЙ. РОЛЬ В ПОВЫШЕНИИ АРТЕРИАЛЬНОГО ДАВЛЕНИЯ. Артериальная гипертензия. 2012;18(6):577-583. https://doi.org/10.18705/1607-419X-2012-18-6-577-583

For citation:


Konradi A.O. Interrelation between sympathetic and renin-angiotensin systems: Role in arterial hypertension. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2012;18(6):577-583. (In Russ.) https://doi.org/10.18705/1607-419X-2012-18-6-577-583

Просмотров: 56


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1607-419X (Print)
ISSN 2411-8524 (Online)